is on, or has been on, the Advisory Board of Angelini, Bayer, Mitsubushi Tanabe Pharma, Nervo, Trigocare International and Worwag Pharma
Oral delivery of therapeutic proteins and peptides: an overview of current technologies and recommendations for bridging from approved intravenous or subcutaneous administration to novel oral regimens
However, treatment becomes important when any of the following are true: The varicocele is causing persistent pain that interferes with daily life There is testicular shrinkage or a clear size difference between the two testicles A semen analysis shows low count, low motility, or abnormal shape There is a fertility goal, either natural conception or improving outcomes for IUI, IVF, or ICSI Testosterone levels are low, and symptoms of low testosterone are present In any of these situations, a urologist or fertility specialist can confirm the varicocele grade and walk you through whether observation, lifestyle changes, or surgical repair is the right next step
Dosing units reality check Frequently Asked Questions What is the core mechanistic difference between IGF-1 LR3 and tesamorelin
In the field of weight loss drug development, the recently disclosed clinical data of Amgens weight loss candidate drug Maridebart Cafraglutide (referred to as MariTide, formerly known as AMG 133) has drawn widespread attention in the industry and is considered a potential Game Changer. The reason why MariTide is seen as a game-changer in the weight loss drug market dominated by Wegovy and Zepbound is an important factor: MariTides molecular modality is a unique antibody-peptide conjugate (also known as Peptibody)